We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+23.4%
1 Year Est. Return
+275.57%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
+$10.7M
Cap. Flow
+$7.44M
Cap. Flow %
5.12%
Top 10 Hldgs %
27.16%
Holding
316
New
137
Increased
28
Reduced
59
Closed
75

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$4.91M
2
EHC icon
Encompass Health
EHC
+$3.58M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$3.43M
4
AMGN icon
Amgen
AMGN
+$3.35M
5
LLY icon
Eli Lilly
LLY
+$2.53M

Sector Composition

Rank Sector Weight
1 Healthcare 48.9%
2 Financials 13.82%
3 Miscellaneous 11.7%
4 Technology 6.61%
5 Consumer Discretionary 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNC icon
1
Centene
CNC
$33.4B
$8.19M 5.63%
+229,544
New +$6.93M
IEF icon
2
iShares 7-10 Year Treasury Bond ETF
IEF
$42.2B
$4.82M 3.31%
+50,000
New +$4.78M
UNH icon
3
UnitedHealth
UNH
$356B
$4.17M 2.86%
+12,063
New +$3.65M
REGN icon
4
Regeneron Pharmaceuticals
REGN
$85.8B
$3.89M 2.67%
6,911
+5,602
+428% +$3.17M
CVS icon
5
CVS Health
CVS
$124B
$3.89M 2.67%
+51,542
New +$3.53M
NBIS
6
Nebius Group N.V.
NBIS
$59.3B
$3.37M 2.31%
+30,000
New +$2.08M
PDD icon
7
Pinduoduo
PDD
$117B
$2.89M 1.99%
+21,855
New +$2.59M
IBIT icon
8
iShares Bitcoin Trust
IBIT
$61.5B
$2.87M 1.97%
44,200
-52,800
-54% -$3.43M
SLNO
9
DELISTED
Soleno Therapeutics
SLNO
$2.79M 1.92%
41,259
-24,060
-37% -$1.78M
BMRN icon
10
BioMarin Pharmaceuticals
BMRN
$12.8B
$2.65M 1.82%
48,866
+4,602
+10% +$263K
LH icon
11
Labcorp
LH
$26.6B
$2.58M 1.77%
8,994
+4,260
+90% +$1.14M
ELV icon
12
Elevance Health
ELV
$88.7B
$2.52M 1.73%
+7,806
New +$2.43M
HCSG icon
13
Healthcare Services Group
HCSG
$1.49B
$2.48M 1.7%
+147,367
New +$2.19M
DGX icon
14
Quest Diagnostics
DGX
$26.3B
$2.3M 1.58%
12,081
+4,074
+51% +$723K
BTSG icon
15
BrightSpring Health Services
BTSG
$12.1B
$2.25M 1.55%
+76,060
New +$1.77M
NXE icon
16
NexGen Energy
NXE
$7.23B
$2.23M 1.53%
249,352
-28,730
-10% -$212K
ALHC icon
17
Alignment Healthcare
ALHC
$2.8B
$2.21M 1.52%
126,929
-100,960
-44% -$1.5M
NVDA icon
18
NVIDIA
NVDA
$5.56T
$2.17M 1.49%
+11,614
New +$2.02M
PNTG icon
19
Pennant Group
PNTG
$1.32B
$1.93M 1.32%
76,411
-63,495
-45% -$1.56M
CNOB icon
20
Center Bancorp
CNOB
$1.62B
$1.88M 1.29%
75,799
-6,015
-7% -$148K
PCVX icon
21
Vaxcyte
PCVX
$9.1B
$1.8M 1.24%
50,076
+4,577
+10% +$152K
EGO icon
22
Eldorado Gold
EGO
$11.2B
$1.68M 1.16%
58,311
+9,557
+20% +$225K
EQX icon
23
Equinox Gold
EQX
$15B
$1.6M 1.1%
142,393
-6,148
-4% -$48.9K
NIO icon
24
NIO
NIO
$9.45B
$1.57M 1.08%
+206,260
New +$1.11M
AA icon
25
Alcoa
AA
$13.3B
$1.56M 1.07%
47,427
+8,182
+21% +$254K

Similar funds

Persistent Asset Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Persistent Asset Partners deployed $7.44M of net new capital in Q3 2025, opening 137 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 229,544 shares worth $8.19M.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $3.43M trimmed.

  • Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
  • Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
  • Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
  • Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
  • Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
  • Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
  • Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.

Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.